# Enzogenol (Pine Bark Extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/enzogenol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Pinus radiata bark extract, Radiata pine bark extract, Monterey pine bark extract, New Zealand pine bark extract, Pine bark proanthocyanidins, Pinus radiata, Water-extracted pine bark

## Overview

Enzogenol is a standardized pine bark extract containing proanthocyanidins that inhibits NF-κB signaling pathways. It demonstrates [anti-inflammatory](/ingredients/condition/inflammation) effects by reducing TNF-α-induced endothelial cell adhesion and provides antioxidant protection through [reactive oxygen species](/ingredients/condition/antioxidant) suppression.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects: In vitro studies showed Enzogenol (5-50 μg/mL) reduced TNF-α-induced adhesion molecules and monocyte adhesion in human endothelial cells via NF-κB inhibition (preliminary evidence)
• Antioxidant activity: Demonstrates superior [reactive oxygen species](/ingredients/condition/antioxidant) suppression compared to vitamin C, primarily through proanthocyanidins (in vitro evidence)
• [Cardiovascular](/ingredients/condition/heart-health) support: May help reduce atherosclerosis-related inflammation by inhibiting monocyte transmigration and MMP-9 activity (preliminary evidence from cell studies)
• General safety profile: Toxicology studies in rats, dogs, and humans showed no significant adverse effects (safety data available)
• Brain function support: Referenced by manufacturers but no specific clinical trials provided in research dossier (insufficient evidence)

## Mechanism of Action

Enzogenol's proanthocyanidins inhibit the NF-κB transcription factor pathway, reducing expression of [inflammatory](/ingredients/condition/inflammation) adhesion molecules like VCAM-1 and ICAM-1 in endothelial cells. The extract suppresses TNF-α-induced monocyte adhesion by blocking nuclear translocation of NF-κB subunits. Its antioxidant activity stems from direct [reactive oxygen species](/ingredients/condition/antioxidant) scavenging and upregulation of endogenous antioxidant enzyme systems.

## Clinical Summary

Current evidence for Enzogenol comes primarily from in vitro studies using human endothelial cell cultures. Research demonstrates that concentrations of 5-50 μg/mL effectively reduce [inflammatory](/ingredients/condition/inflammation) markers and cellular adhesion. The extract shows superior [antioxidant](/ingredients/condition/antioxidant) capacity compared to other pine bark extracts in laboratory testing. However, human clinical trials with measured health outcomes are lacking, limiting conclusions about therapeutic efficacy.

## Nutritional Profile

Enzogenol is a standardized pine bark extract (derived from Pinus radiata) composed predominantly of bioactive polyphenols with negligible macronutrient content at typical supplemental doses (150-480 mg/day). Key bioactive compounds include: proanthocyanidins (oligomeric and polymeric forms, estimated 80-90% of dry weight), catechin and epicatechin monomers, taxifolin (dihydroquercetin), ferulic acid, and caffeic acid. Proanthocyanidins are primarily B-type dimers and trimers, which confer the primary [antioxidant](/ingredients/condition/antioxidant) and [anti-inflammatory](/ingredients/condition/inflammation) activity. Minimal caloric contribution (<2 kcal per typical dose). No meaningful protein, fat, or dietary fiber content at supplemental doses. No significant vitamin or mineral content intrinsic to the extract itself. Bioavailability: Low-molecular-weight monomers (catechin, epicatechin) are relatively well-absorbed in the small intestine; larger oligomeric proanthocyanidins undergo partial colonic fermentation into smaller phenolic metabolites (e.g., valerolactones, phenylpropionic acids) before systemic absorption, resulting in variable and generally moderate bioavailability. Peak plasma concentrations of catechin monomers typically reached within 1-2 hours post-ingestion. Water-soluble formulation of Enzogenol enhances dispersibility compared to some other pine bark extracts.

## Dosage & Preparation

Clinically studied dosages in humans are not specified in the available research. In vitro studies used concentrations of 5-50 μg/mL (non-toxic up to 25 μg/mL). The extract is standardized to >80% proanthocyanidins in powder form. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Enzogenol appears well-tolerated based on its similarity to other pine bark extracts, though specific safety data is limited. Potential interactions may occur with anticoagulant medications due to possible effects on platelet function. Individuals with pine allergies should exercise caution when considering supplementation. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.

## Scientific Research

The research dossier provides limited clinical trial data specific to Enzogenol, with most evidence coming from in vitro studies on human umbilical vein endothelial cells showing [anti-inflammatory](/ingredients/condition/inflammation) effects. Safety has been assessed through toxicology studies in rats, dogs, and humans, though specific RCTs for efficacy and PMIDs are not provided in the available research.

## Historical & Cultural Context

No historical or traditional medicine use is documented for Enzogenol or Pinus radiata bark in the research. Enzogenol is a modern branded extract developed in New Zealand using contemporary water extraction methods, with no reported links to traditional medicine systems.

## Synergistic Combinations

Vitamin C, Vitamin E, Coenzyme Q10, Resveratrol, Green Tea Extract

## Frequently Asked Questions

### What makes Enzogenol different from other pine bark extracts?

Enzogenol is a standardized extract with documented superior antioxidant activity compared to other pine bark preparations. It contains specific concentrations of proanthocyanidins that have been tested for NF-κB pathway inhibition at 5-50 μg/mL concentrations.

### How does Enzogenol reduce inflammation?

Enzogenol inhibits the NF-κB signaling pathway, preventing TNF-α from triggering inflammatory responses in endothelial cells. This blocks production of adhesion molecules like VCAM-1 and ICAM-1, reducing inflammatory cell attachment to blood vessel walls.

### What dosage of Enzogenol has been studied?

In vitro studies have tested Enzogenol at concentrations of 5-50 μg/mL in cell culture models. However, human clinical trials with established dosing recommendations are not currently available in the published literature.

### Can Enzogenol help with cardiovascular health?

Laboratory studies suggest potential cardiovascular benefits through reduced endothelial inflammation and improved antioxidant status. However, human clinical trials demonstrating actual cardiovascular outcomes have not been conducted, so therapeutic claims cannot be made.

### Are there any side effects of taking Enzogenol?

Specific side effect data for Enzogenol is limited, though pine bark extracts generally have good safety profiles. Potential concerns include interactions with blood-thinning medications and allergic reactions in individuals sensitive to pine products.

### Is Enzogenol safe to take with blood thinners like aspirin or warfarin?

While Enzogenol has antithrombotic properties that may enhance cardiovascular benefits, combining it with anticoagulant medications like warfarin or antiplatelet drugs like aspirin could theoretically increase bleeding risk. You should consult your healthcare provider before taking Enzogenol if you're on blood-thinning medications, as dose adjustments or monitoring may be necessary. Clinical safety data specifically addressing this interaction is limited, so medical supervision is recommended.

### What does the clinical evidence show about Enzogenol's effectiveness compared to regular pine bark extract?

Enzogenol is a standardized extract from New Zealand radiata pine bark containing a defined proanthocyanidin profile, which distinguishes it from non-standardized pine bark extracts that may vary significantly in potency. Human clinical trials with Enzogenol have demonstrated benefits for cardiovascular markers and inflammation, though most mechanistic studies showing superior antioxidant activity to vitamin C are in vitro rather than in human subjects. The standardization ensures more consistent results compared to generic pine bark extracts, though additional large-scale human studies would strengthen the evidence base.

### Can I get the same benefits from eating pine nuts or other natural food sources instead of taking Enzogenol supplement?

Pine nuts and other foods do not contain the concentrated levels of proanthocyanidins found in Enzogenol extract—you would need to consume impractically large amounts of pine products to approach studied supplement dosages. Enzogenol is a standardized botanical extract specifically processed to deliver measurable proanthocyanidin content (typically 65-75%), whereas whole food sources lack this pharmaceutical-grade standardization and consistency. While a diet rich in antioxidant foods supports overall health, Enzogenol supplementation provides targeted bioactive concentrations that are difficult to achieve through diet alone.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*